ETF Managers Group’s Codiak BioSciences, Inc. Common Stock CDAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-7,107
| Closed | -$26K | – | 851 |
|
|
2022
Q2 | $26K | Buy |
7,107
+323
| +5% | +$1.18K | ﹤0.01% | 732 |
|
|
2022
Q1 | $43K | Buy |
6,784
+23
| +0.3% | +$146 | ﹤0.01% | 665 |
|
|
2021
Q4 | $74K | Sell |
6,761
-1,007
| -13% | -$11K | ﹤0.01% | 651 |
|
|
2021
Q3 | $125K | Buy |
7,768
+1,265
| +19% | +$20.4K | ﹤0.01% | 633 |
|
|
2021
Q2 | $123K | Sell |
6,503
-100
| -2% | -$1.89K | ﹤0.01% | 618 |
|
|
2021
Q1 | $92K | Sell |
6,603
-2,525
| -28% | -$35.2K | ﹤0.01% | 641 |
|
|
2020
Q4 | $256K | Buy |
+9,128
| New | +$256K | 0.01% | 566 |
|